These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32109594)

  • 1. Multidimensional evaluation is necessary to assess hand function in patients with Charcot-Marie-Tooth disease type 1A.
    Reynaud V; Conforto I; Givron P; Clavelou P; Cornut-Chauvinc C; Taithe F; Pereira B; Coudeyre E
    Ann Phys Rehabil Med; 2021 Mar; 64(2):101362. PubMed ID: 32109594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripod pinch strength and thumb opposition are the major determinants of manual dexterity in Charcot-Marie-Tooth disease type 1A.
    Videler AJ; Beelen A; van Schaik IN; Verhamme C; van den Berg LH; de Visser M; Nollet F
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):828-33. PubMed ID: 20562406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of muscle strength and manual dexterity in patients with Charcot-Marie-Tooth disease.
    Kobesova A; Nyvltova M; Kraus J; Kolar P; Sardina A; Mazanec R; Andel R
    J Hand Ther; 2016; 29(1):66-72; quiz 72. PubMed ID: 26847322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease.
    Cornett KM; Menezes MP; Bray P; Halaki M; Shy RR; Yum SW; Estilow T; Moroni I; Foscan M; Pagliano E; Pareyson D; Laurá M; Bhandari T; Muntoni F; Reilly MM; Finkel RS; Sowden J; Eichinger KJ; Herrmann DN; Shy ME; Burns J;
    JAMA Neurol; 2016 Jun; 73(6):645-51. PubMed ID: 27043305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor axon loss is associated with hand dysfunction in Charcot-Marie-Tooth disease 1a.
    Videler AJ; van Dijk JP; Beelen A; de Visser M; Nollet F; van Schaik IN
    Neurology; 2008 Oct; 71(16):1254-60. PubMed ID: 18852440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manual dexterity in hereditary motor and sensory neuropathy type 1a: severity of limitations and feasibility and reliability of two assessment instruments.
    Videler AJ; Beelen A; van Schaik IN; de Visser M; Nollet F
    J Rehabil Med; 2008 Feb; 40(2):132-6. PubMed ID: 18509578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a new hand function outcome measure in individuals with Charcot-Marie-Tooth disease.
    Prada V; Robbiano G; Mennella G; Hamedani M; Bellone E; Grandis M; Schenone A; Zuccarino R
    J Peripher Nerv Syst; 2020 Dec; 25(4):413-422. PubMed ID: 33140522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor performance deterioration accelerates after 50 years of age in Charcot-Marie-Tooth type 1A patients.
    Tozza S; Bruzzese D; Pisciotta C; Iodice R; Esposito M; Dubbioso R; Ruggiero L; Topa A; Spina E; Santoro L; Manganelli F
    Eur J Neurol; 2018 Feb; 25(2):301-306. PubMed ID: 29053907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Employment status of patients with Charcot-Marie-Tooth type 1A.
    Bjelica B; Brankovic M; Bozovic I; Palibrk A; Kacar A; Rakocevic-Stojanovic V
    Acta Neurol Belg; 2022 Jun; 122(3):641-646. PubMed ID: 33491123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Handwriting difficulties of children with Charcot-Marie-Tooth disease type 1A.
    Kunovsky D; Cordier R; Bray P; Burns J
    J Peripher Nerv Syst; 2017 Mar; 22(1):34-38. PubMed ID: 27917570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome measures in the clinical evaluation of ambulatory Charcot-Marie-Tooth 1A subjects.
    Mori L; Prada V; Signori A; Pareyson D; Piscosquito G; Padua L; Pazzaglia C; Fabrizi GM; Smania N; Picelli A; Schenone A;
    Eur J Phys Rehabil Med; 2019 Feb; 55(1):47-55. PubMed ID: 29898585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hand function in Charcot Marie Tooth: test retest reliability of some measurements.
    Svensson E; Häger-Ross C
    Clin Rehabil; 2006 Oct; 20(10):896-908. PubMed ID: 17008341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in hereditary neuropathy with liability to pressure palsies is as impaired as in Charcot-Marie-Tooth disease type 1A.
    Bjelica B; Peric S; Bozovic I; Jankovic M; Brankovic M; Palibrk A; Rakocevic Stojanovic V
    Acta Neurol Belg; 2021 Dec; 121(6):1481-1486. PubMed ID: 32335868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability and validity of the Manual Ability Measure-36 in persons with Charcot-Marie-Tooth disease.
    Poole JL; Huffman M; Hunter A; Mares C; Siegel P
    J Hand Ther; 2015; 28(4):364-7; quiz 368. PubMed ID: 26318522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamometry of intrinsic hand muscles in patients with Charcot-Marie-Tooth disease.
    Selles RW; van Ginneken BT; Schreuders TA; Janssen WG; Stam HJ
    Neurology; 2006 Dec; 67(11):2022-7. PubMed ID: 17159111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypothesis of overwork weakness in Charcot-Marie-Tooth: a critical evaluation.
    van Pomeren M; Selles RW; van Ginneken BT; Schreuders TA; Janssen WG; Stam HJ
    J Rehabil Med; 2009 Jan; 41(1):32-4. PubMed ID: 19197566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy.
    Alberti MA; Mori L; Francini L; Poggi I; Monti Bragadin M; Bellone E; Grandis M; Maggi G; Reni L; Sormani MP; Tacchino A; Padua L; Prada V; Bove M; Schenone A
    J Peripher Nerv Syst; 2015 Dec; 20(4):410-4. PubMed ID: 26456943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients.
    Mannil M; Solari A; Leha A; Pelayo-Negro AL; Berciano J; Schlotter-Weigel B; Walter MC; Rautenstrauss B; Schnizer TJ; Schenone A; Seeman P; Kadian C; Schreiber O; Angarita NG; Fabrizi GM; Gemignani F; Padua L; Santoro L; Quattrone A; Vita G; Calabrese D; ; Young P; Laurà M; Haberlová J; Mazanec R; Paulus W; Beissbarth T; Shy ME; Reilly MM; Pareyson D; Sereda MW
    Neuromuscul Disord; 2014 Nov; 24(11):1003-17. PubMed ID: 25085517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot Function Index: A Promising Questionnaire for Individuals With Charcot-Marie-Tooth Disease Type 1A.
    Bihel L; Reynaud V; Givron P; Clavelou P; Cornut-Chauvinc C; Pereira B; Thomas E; Taithe F; Coudeyre E
    Arch Phys Med Rehabil; 2019 Dec; 100(12):2403-2406. PubMed ID: 31255638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and upper limb disability in Charcot-Marie-Tooth disease: A pilot study.
    Mori L; Schenone C; Cotellessa F; Ponzano M; Aiello A; Lagostina M; Massucco S; Marinelli L; Grandis M; Trompetto C; Schenone A
    Front Neurol; 2022; 13():964254. PubMed ID: 36277933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.